en · de · es · pt
assay-notes.peptides4800.com › Faq › Selank Origin And Chemical Identity — Hands-On Walkthrough

Selank Origin And Chemical Identity — Hands-On Walkthrough

By Editorial Desk · published 2025-07-22 · last reviewed 2025-09-13 · Faq

This is a working overview of peptide stability, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2025-09-13. Anything still debated is marked as such rather than presented as settled.

Selank Origin and Chemical Identity

Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.

The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.

Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.

Identity and Structural Background

Development work on the compound began in the 1980s and 1990s at the Institute of Molecular Genetics in Moscow, within the same research programme that produced the peptide Semax. Early investigators sought a tuftsin derivative with improved resistance to enzymatic breakdown and with activity in the central nervous system after peripheral administration. Most of the primary literature from this period was published in Russian, a factor that still shapes how easily the findings can be checked by outside groups.

Naming for this compound is not fully standardised in English sources. The spelling Selanc appears in some transliterations, and catalogue entries may instead list the peptide sequence itself as the identifier. Reference material sometimes groups it with other short synthetic peptides studied for behavioural effects, which can create confusion when citations are compared. Distinguishing the exact sequence from related tuftsin analogues is therefore a practical first step when reviewing any dataset or specification sheet.

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, frequently abbreviated as TKPRPGP. It was designed as a structural analogue of tuftsin, a naturally occurring tetrapeptide released by enzymatic cleavage of the immunoglobulin heavy chain. The two additional proline residues at the C-terminal end extend the parent chain and change how the molecule behaves in solution. The free peptide has a calculated molecular mass of approximately 751.9 g/mol and is generally supplied as a lyophilised white to off-white powder.

Selank at a glance

PropertyValueNotes
Chemical classSynthetic heptapeptideAnalog of the tetrapeptide tuftsin
SequenceThr-Lys-Pro-Arg-Pro-Gly-ProReported consistently across pharmacopoeial descriptions
AppearanceWhite to off-white lyophilized powderTypical form of research-grade material
SolubilityFreely soluble in waterAqueous buffers; poor in nonpolar solvents
Typical storage temperature-20 degrees CelsiusLyophilized powder; protect from moisture

Storage, Analysis, and Regulatory Status

Selank is a hydrophilic peptide and dissolves readily in water and in aqueous buffers. The lyophilised powder is typically a white to off-white solid. Because short peptides are prone to hydrolysis and oxidation, handling benefits from limiting exposure to heat, moisture and strong light. Working solutions are commonly prepared in sterile water or saline, and repeated freeze-thaw cycles are avoided to reduce aggregation and loss of activity. These practices reflect general laboratory convention rather than published stability specifications.

Dry powder is normally held at -20 degrees Celsius or lower, in a sealed container with desiccant and protection from light. Reconstituted solutions are usually kept at 2 to 8 degrees Celsius for short periods and frozen for longer ones. Proline residues at several positions are generally associated with some resistance to peptidase attack, but chemical stability still declines at neutral to alkaline pH and at elevated temperature. Exact shelf-life figures are product-specific and are not standardised across suppliers.

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.

Related pages on this site

Analytical Methods And Storage Stability

Peptide stability depends strongly on temperature, moisture, and pH. Lyophilized Selank is generally most stable when stored cold and dry, with freezer temperatures commonly used for long-term storage. In solution, the compound is susceptible to hydrolysis and to microbial growth if it is not handled aseptically. The C-terminal proline-rich extension appears to slow enzymatic cleavage relative to tuftsin, though quantitative degradation rates vary with the matrix and the conditions tested. Published stability data specific to Selank remain sparse.

Quality assessment of Selank samples typically combines purity determination with identity confirmation and counter-ion analysis. Purity is usually reported as a percentage by chromatographic area, with values above 95 percent often quoted for research-grade material. Water content and residual solvents are checked in lyophilized batches because they affect both stability and accurate mass determination. A reported purity figure does not by itself establish that a sample is the intended sequence, so orthogonal methods are needed to rule out sequence isomers or truncation products.

Characterization of Selank in laboratory settings relies on standard peptide analytical techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and degradation products, while mass spectrometry confirms molecular identity through accurate mass measurement. Amino acid analysis and peptide sequencing verify the primary structure when reference material is unavailable. Because Selank is a short chain, fragmentation-based analysis produces a diagnostic ion pattern that supports confident identification.

Background from the literature

It follows that any equilibrium of this kind can be characterized either by the standard free energy change or by the equilibrium constant. In practice concentrations are more useful than activities. Activities can be calculated from concentrations if the activity coefficient are known, but this is rarely the case. Sometimes activity coefficients can be calculated using, for example, Pitzer equations or Specific ion interaction theory. Otherwise conditions must be adjusted so that activity coefficients do not vary much. For ionic solutions this is achieved by using a background ionic medium at a high concentration relative to the concentrations of the species in equilibrium. If activity coefficients are unknown they may be subsumed into the equilibrium constant, which becomes a concentration quotient. Each activity ai is assumed to be the product of a concentration, [Ai], and an activity coefficient, γi:

=== Industrial farms === Little research has been done on humane methods of killing insects for consumption. The most common killing methods used by entomophagy companies in the Netherlands are freezing and dry-freezing (i.e., freezing and reducing pressure in order to extract water from the insects). Protix Biosystems kills its black soldier flies by shredding, since its end product is a powder. Death takes less than a second. Tarique Arsiwalla at Protix said shredding makes sense because Western consumers are more likely to accept powdered insects than whole insects. The Jagran company has tried asphyxiation, cooling, freeze-drying, boiling, and shredding. Managing Director Walter Jansen believes that shredding is most humane. The Kreca company kills its animal-feed insects by putting them into a fridge or freeze-drying them. Insects destined for human consumption are first sterilized in hot water and then are refrigerated or freeze-dried. FAO's "Edible insects" report suggests: "Insect-killing methods that would reduce suffering include freezing or instantaneous techniques such as shredding."

An individual or juridical or other body authorized under applicable law to consent, on behalf of a prospective subject, to the subject's participation in the clinical trial. (ICH E6) Levels of evidence

Kripke explained that Soldier Boy was Vought's version of Wayne since he worked for them for several decades and is someone who comes from a different era, but still has the ego and ambition for which he described him as the "Homelander before Homelander." Many of the changes were applied to give Homelander a threat just as he is finally starting to take control of Vought, but Kripke wanted to ensure that it was someone that the character has never faced before with someone that has the same strength as him and could actually fight him, for which he considered Soldier Boy to be the best match. Besides introducing Soldier Boy, the season also introduces the superhero team Payback for which the character was leader. Unlike in the comics where the team served as a rival of the Seven, Payback has already disbanded by the time where the series take place; it used to be the world's premiere team of supes before the Seven was formed and is described as "the Seven before the Seven." Kripke explained that the changes were mostly done to get a deeper exploration of Vought's history by exploring the past of each member of the teams, so the writers are allowed to shed light on the show's present. The season also includes a storyline focused mostly on Kimiko Miyashiro. As the season progresses, Kimiko goes through an emotional arc for which she starts learning to express herself after spending most of her life doing what other people wanted.

Sources: en.wikipedia.org

Further detail

anaerobic 1. Describing conditions in which diatomic oxygen is entirely absent, as opposed to aerobic conditions. 2. Describing an organism that is able to survive and grow in the absence of diatomic oxygen, or a pathway or process characterized by the absence of diatomic oxygen; e.g. anaerobic respiration.

=== Compensatory mutations in RNA === As the function of a RNA molecule is dependent on its structure, the structure of RNA molecules is evolutionarily conserved. Therefore, any mutation that alters the stable structure of RNA molecules must be compensated by other compensatory mutations. In the context of RNA, the sequence of the RNA can be considered as ' genotype' and the structure of the RNA can be considered as its 'phenotype'. Since RNAs have relatively simpler composition than proteins, the structure of RNA molecules can be computationally predicted with high degree of accuracy. Because of this convenience, compensatory mutations have been studied in computational simulations using RNA folding algorithms.

Breakable PAGE SDS-PAGE (DPAGE, dissolvable PAGE), two-dimensional gel electrophoresis or chromatography is used for separation of MeCAT labelled proteins. Flow-injection ICP-MS analysis of protein bands or spots from DPAGE SDS-PAGE gels can be easily performed by dissolving the DPAGE gel after electrophoresis and staining of the gel. MeCAT labelled proteins are identified and relatively quantified on peptide level by MALDI-MS or ESI-MS.

Sources: en.wikipedia.org

Frequently asked questions

What is Selank?

Selank is a synthetic seven-amino-acid peptide modeled on tuftsin, a fragment of the immunoglobulin G heavy chain. It was designed in Russia to combine anxiolytic and immunomodulatory properties in one molecule.

How does it relate to tuftsin?

The first four residues of Selank reproduce the tuftsin sequence Thr-Lys-Pro-Arg. A Pro-Gly-Pro extension at the C-terminus was added to slow enzymatic breakdown and extend residence time.

Is Selank an approved medicine?

It holds marketing authorization in Russia, where nasal drop formulations are sold. No equivalent approval exists in the European Union, the United States, or most other countries.

What is the peptide sequence of Selank?

The sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, commonly written as TKPRPGP. It shares the first four residues with tuftsin and carries three prolines in the chain. The proline-rich tail is the main structural feature that separates it from the parent tetrapeptide.

Network